» Articles » PMID: 29707568

Current Concepts of Neurodegenerative Mechanisms in Alzheimer's Disease

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2018 May 1
PMID 29707568
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Neurodegenerative diseases are hereditary or sporadic conditions that result in the progressive loss of the structure and function of neurons as well as neuronal death. Although a range of diseases lie under this umbrella term, Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common neurodegenerative diseases that affect a large population around the globe. Alzheimer's disease is characterized by the abnormal accumulation of extracellular amyloid- plaques and intraneuronal neurofibrillary tangles in brain regions and manifests as a type of dementia in aged individuals that results in memory loss, multiple cognitive abnormalities, and intellectual disabilities that interfere with quality of life. Since the discovery of AD, a wealth of new information has emerged that delineates the causes, mechanisms of disease, and potential therapeutic agents, but an effective remedy to cure the diseases has not been identified yet. This could be because of the complexity of the disease process, as it involves various contributing factors that include environmental factors and genetic predispositions. This review summarizes the current understanding on neurodegenerative mechanisms that lead to the emergence of the pathology of AD.

Citing Articles

Ultra-Sensitive Nanoplatform for Detection of Brain-Derived Neurotrophic Factor Using Silica-Coated Gold Nanoparticles with Enzyme-Formed Quantum Dots.

Yu S, Choi J, Ahn Y, Kim M, Kim N, Lee H Molecules. 2025; 30(3).

PMID: 39942807 PMC: 11820963. DOI: 10.3390/molecules30030699.


Lipidome disruption in Alzheimer's disease brain: detection, pathological mechanisms, and therapeutic implications.

He S, Xu Z, Han X Mol Neurodegener. 2025; 20(1):11.

PMID: 39871348 PMC: 11773937. DOI: 10.1186/s13024-025-00803-6.


The epigenetic modification of DNA methylation in neurological diseases.

Li L, Chen R, Zhang H, Li J, Huang H, Weng J Front Immunol. 2024; 15:1401962.

PMID: 39376563 PMC: 11456496. DOI: 10.3389/fimmu.2024.1401962.


8-Week Extract Administration Improves Submaximal Exercise Capacity in Mice by Enhancing Skeletal Muscle Antioxidant Gene Expression and Plasma Antioxidant Capacity.

Huang J, Tong Y, Wang S, Tagawa T, Seki Y, Ma S Antioxidants (Basel). 2024; 13(9).

PMID: 39334806 PMC: 11428225. DOI: 10.3390/antiox13091147.


QUANTIFYING HIPPOCAMPAL SHAPE ASYMMETRY IN ALZHEIMER'S DISEASE USING OPTIMAL SHAPE CORRESPONDENCES.

Zhu S, Zawar I, Kapur J, Fletcher P Proc IEEE Int Symp Biomed Imaging. 2024; 2024.

PMID: 39323495 PMC: 11423258. DOI: 10.1109/isbi56570.2024.10635697.


References
1.
Tai H, Serrano-Pozo A, Hashimoto T, Frosch M, Spires-Jones T, Hyman B . The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am J Pathol. 2012; 181(4):1426-35. PMC: 3463637. DOI: 10.1016/j.ajpath.2012.06.033. View

2.
Zahid S, Khan R, Oellerich M, Ahmed N, Asif A . Differential S-nitrosylation of proteins in Alzheimer's disease. Neuroscience. 2013; 256:126-36. DOI: 10.1016/j.neuroscience.2013.10.026. View

3.
Rhein V, Song X, Wiesner A, Ittner L, Baysang G, Meier F . Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proc Natl Acad Sci U S A. 2009; 106(47):20057-62. PMC: 2774257. DOI: 10.1073/pnas.0905529106. View

4.
Medeiros R, Prediger R, Passos G, Pandolfo P, Duarte F, Franco J . Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid beta protein. J Neurosci. 2007; 27(20):5394-404. PMC: 6672347. DOI: 10.1523/JNEUROSCI.5047-06.2007. View

5.
Janson J, Laedtke T, Parisi J, OBrien P, Petersen R, Butler P . Increased risk of type 2 diabetes in Alzheimer disease. Diabetes. 2004; 53(2):474-81. DOI: 10.2337/diabetes.53.2.474. View